EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reappraisal of soft tissue myoepithelial tumors by DNA methylation profiling reveals an epigenetically distinct group of mostly fusion-driven neoplasms

Faizan Malik, Selene C Koo, Nasir Ud Din, Quynh T Tran, Oscar Lopez-Nunez, Sabina Barresi, Silvia Vallese, Giuseppe Milano, Evelina Miele, Michael R Clay, Rita Alaggio, Brent A Orr

Virchows Archiv · 2025

DOI: 10.1007/s00428-024-03977-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Virchows Archiv, 2025. Verfasst von Faizan Malik und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, MS 250, St. Jude Children's Research Hospital, 262 Danny Thomas Pl, Memphis, TN, 38105, USA. Hauptthemen laut MEDLINE: DNA Methylation, Soft Tissue Neoplasms, Myoepithelioma, Biomarkers, Tumor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Italian Ministry of Health, American Lebanese Syrian Associated Charities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Soft tissue myoepithelial tumors (METs) are diagnostically challenging tumors that require careful histologic and immunohistochemical characterization for accurate classification. Nearly half of METs show recurrent EWSR1 or FUS gene rearrangements with a diverse set of fusion partners. The diversity of fusion partners and lack of known driver abnormalities in many cases raises the question of whether METs represent a uniformly distinct tumor entity. To address this question, we performed careful histopathologic and molecular analysis, including DNA methylation profiling (DNA-MP) and fusion testing, on a cohort of 30 institutionally diagnosed METs from 29 patients. On histologic and immunophenotypic evaluation, 22 of 30 tumors diagnosed as MET fulfilled strict histologic and immunophenotypic criteria. Among those failing to meet criteria, most were reclassified as another tumor entity by DNA-MP. Seven tumors meeting criteria grouped with another sarcoma reference type by DNA-MP, with confirmation of the characteristic driver abnormality of that tumor in selected cases. The remaining tumors histologically “consistent” with METs ( n = 15) formed a distinct epigenetic cluster, independent of other reference entities. Recurrent gene fusions were identified in 11 of 15 tumors in this epigenetically distinct group, including EWSR1 :: KLF15 ( n = 4), EWSR1 :: PBX3 ( n = 2), and EWSR1 :: POU5F1 ( n = 1) rearrangements. Clinicopathologic correlation suggests that EWSR1 :: KLF15 tumors are enriched in pediatric patients with aggressive histology. Our work shows that at least a subset of METs falls within an epigenetically distinct but heterogenous group. Furthermore, DNA-MP provides a useful adjunct to other molecular testing to help distinguish METs from histologic mimics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationSoft Tissue NeoplasmsMyoepitheliomaBiomarkers, TumorEpigenesis, GeneticOncogene Proteins, FusionHumansMaleFemaleAdultMiddle AgedAgedYoung AdultAdolescentChildChild, PreschoolGene Fusion

Stichwörter der Autor:innen

DNA methylationEWSR1KLF15Myoepithelial tumorMyoepitheliomaPBX3

Substanzen

Biomarkers, TumorOncogene Proteins, Fusion

Autor:innen und Institutionen

  • Department of Pathology, MS 250, St. Jude Children's Research Hospital, 262 Danny Thomas Pl, Memphis, TN, 38105, USA.
  • Department of Pathology and Laboratory Medicine, Aga Khan University Hospital, Karachi, Pakistan.
  • Department of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Pathology Unit, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.
  • Oncology Unit, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.
  • Department of Pathology, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.

Förderung

  • NCI NIH HHS
  • Italian Ministry of Health
  • American Lebanese Syrian Associated Charities
  • National Cancer Institute

Zitieren

APA

Malik, F., Koo, S. C., Din, N. U., Tran, Q. T., Lopez-Nunez, O., Barresi, S., Vallese, S., Milano, G., Miele, E., Clay, M. R., Alaggio, R., & Orr, B. A. (2025). Reappraisal of soft tissue myoepithelial tumors by DNA methylation profiling reveals an epigenetically distinct group of mostly fusion-driven neoplasms. Virchows Archiv. https://doi.org/10.1007/s00428-024-03977-4

Vancouver

Malik F, Koo SC, Din NU, Tran QT, Lopez-Nunez O, Barresi S, et al. Reappraisal of soft tissue myoepithelial tumors by DNA methylation profiling reveals an epigenetically distinct group of mostly fusion-driven neoplasms. Virchows Archiv. 2025. doi:10.1007/s00428-024-03977-4

BibTeX
@article{Malik2025,
  author = {Malik, Faizan and Koo, Selene C and Din, Nasir Ud and Tran, Quynh T and Lopez-Nunez, Oscar and Barresi, Sabina and Vallese, Silvia and Milano, Giuseppe and Miele, Evelina and Clay, Michael R and Alaggio, Rita and Orr, Brent A},
  title = {Reappraisal of soft tissue myoepithelial tumors by DNA methylation profiling reveals an epigenetically distinct group of mostly fusion-driven neoplasms},
  journal = {Virchows Archiv},
  year = {2025},
  doi = {10.1007/s00428-024-03977-4}
}
Kostenlos starten →